| ATCC 33726| CCUG 45939| CIP 104777| DSM 44481| IFO 15556| JCM 6044| NBRC 15556| Nocardia nova| Nocardia nova Tsukamura 1983| strain R.E. Gordon R443| strain Tsukamura 23095| VKM Ac-1971
Pulmonary Nocardiosis: Pulmonary nocardiosis is the most common manifestation of Nocardia nova infection and typically occurs through inhalation of the bacteria. Symptoms may include cough, chest pain, fever, difficulty breathing, and pneumonia-like symptoms. In severe cases, the infection can lead to lung abscesses or disseminate to other organs.
Cutaneous Nocardiosis: Cutaneous nocardiosis occurs when Nocardia nova enters the body through breaks in the skin, such as cuts, wounds, or puncture injuries. This can lead to localized skin infections, abscesses, cellulitis, or nodules. The skin lesions may be painful, red, swollen, and may develop pus.
Disseminated Nocardiosis: In immunocompromised individuals, Nocardia nova infections can disseminate beyond the lungs or skin to other organs and tissues, causing disseminated disease. Disseminated nocardiosis is a serious condition that can affect multiple organ systems, including the brain, kidneys, liver, bones, and eyes. Symptoms vary depending on the organs involved and may include fever, weight loss, neurological symptoms, and organ dysfunction.
Central Nervous System Nocardiosis: Nocardia nova can cause infections of the central nervous system (CNS), leading to conditions such as brain abscesses, meningitis, or spinal cord infections. Central nervous system nocardiosis is a severe and potentially life-threatening condition that requires prompt diagnosis and treatment with antibiotics.
Treatment Challenges: Nocardia nova infections can be challenging to treat due to the bacterium's resistance to many commonly used antibiotics. Treatment typically involves prolonged courses of antibiotics, often in combination therapy, tailored to the specific strain and antimicrobial susceptibility patterns. Early detection and treatment are essential for improving outcomes and preventing complications.
The above data is from 1000 Healthy Individuals done using Shotgun(10 Millions reads) provide courtesy of Precision Biome.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
![]() |
NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | Average | Median | Minimum | Maximum | Std.Dev. | Skew | 25 - 75 Percentile | 5 - 95 Percentile | Lab Ranges | Box-Plot-Whiskers | Harmonic Mean | Geometric Mean | Obs. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thorne | 0.0952 | 0.0003 | 0.0002 | 0.0001 | 0.0013 | 0.0003 | 1.1728 | 0.0001 - 0.0005 | 0.0001 - 0.001 | -0.0003 - 0.001 | -0.0005 - 0.001 | 0.0002 | 0.0002 | 18 |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
PrecisionBiome | 2.4236349418060854E-05 | 2.4236349418060854E-05 | 0 | 0 |
|
And display level must be raised above public.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]